Characterization of drug interactions with serum proteins by using high-performance affinity chromatography

David S. Hage, Jeanethe Anguizola, Omar Barnaby, Abby Jackson, Michelle J. Yoo, Efthimia Papastavros, Erika Pfaunmiller, Matt Sobansky, Zenghan Tong

Research output: Contribution to journalArticle

54 Scopus citations


The binding of drugs with serum proteins can affect the activity, distribution, rate of excretion, and toxicity of pharmaceutical agents in the body. One tool that can be used to quickly analyze and characterize these interactions is high-performance affinity Chromatography (HPAC). This review shows how HPAC can be used to study drug-protein binding and describes the various applications of this approach when examining drug interactions with serum proteins. Methods for determining binding constants, characterizing binding sites, examining drug-drug interactions, and studying drug-protein dissociation rates will be discussed. Applications that illustrate the use of HPAC with serum binding agents such as human serum albumin, ai-acid glycoprotein, and lipoproteins will be presented. Recent developments will also be examined, such as new methods for immobilizing serum proteins in HPAC columns, the utilization of HPAC as a tool in personalized medicine, and HPAC methods for the high-throughput screening and characterization of drug-protein binding.

Original languageEnglish (US)
Pages (from-to)313-328
Number of pages16
JournalCurrent Drug Metabolism
Issue number4
StatePublished - May 1 2011



  • Drug-protein binding
  • High-performance affinity chromatography
  • High-throughput screening
  • Human serum albumin
  • Lipoproteins
  • Personalized medicine
  • α-acid glycoprotein

ASJC Scopus subject areas

  • Pharmacology
  • Clinical Biochemistry

Cite this

Hage, D. S., Anguizola, J., Barnaby, O., Jackson, A., Yoo, M. J., Papastavros, E., Pfaunmiller, E., Sobansky, M., & Tong, Z. (2011). Characterization of drug interactions with serum proteins by using high-performance affinity chromatography. Current Drug Metabolism, 12(4), 313-328.